<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01257282</url>
  </required_header>
  <id_info>
    <org_study_id>U-07-001</org_study_id>
    <nct_id>NCT01257282</nct_id>
  </id_info>
  <brief_title>Prevalence and Prognostic Value of Unrecognized Myocardial Injury in Stable Coronary Artery Disease (PUMI)</brief_title>
  <acronym>PUMI</acronym>
  <official_title>Prevalence and Prognostic Value of Unrecognised Myocardial Injury in Stable Coronary Artery Disease (PUMI)- a Multicenter, Observational Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study includes patients with stable coronary artery disease without previously known
      myocardial infarction, and investigates the prevalence of clinically unrecognized myocardial
      damage and its prognostic implication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A substantial portion of all myocardial infarctions are not clinically recognized, but the
      myocardial damage can be recognized afterwards e g by magnetic resonance imaging (MRI). This
      study includes patients with stable coronary artery disease without previously known
      myocardial infarction, and investigates the prevalence of clinically unrecognised myocardial
      damage (UMI), and the prognostic value of UMI regarding new cardiac events.

      In a subset of the patients, the biologic intra-individual variability of troponin and other
      biochemical markers will be investigated (substudy protocol).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac events defined as a composite of death, resuscitated cardiac arrest, spontaneous acute myocardial infarction and hospitalisation for congestive heart failure or unstable angina.</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of unrecognized myocardial infarction</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Size and localisation of unrecognized myocardial infarction</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree and localization of artherosclerotic lesions at a coronary angiogram</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure related acute myocardial infarction</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular mass and dimensions, levels of troponin and other biochemical markers, electrocardiography (ECG), anthropometric data</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term mortality, cardiac mortality and incidence of acute myocardial infarction</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">275</enrollment>
  <condition>Stable Angina Pectoris</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma samples for biochemical markers. Whole blood samples for extraction of DNA for genetic
      analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable coronary artery disease without previously known myocardial infarction
        or coronary intervention
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptoms of stable angina pectoris according to the treating physician

          -  scheduled for coronary angiography

          -  written informed consent

        Exclusion Criteria:

          -  pathological Q-wave in the 12-lead resting ECG

          -  known previous myocardial infarction

          -  previous PCI (percutaneous coronary intervention) or CABG (coronary artery bypass
             graft)

          -  history of congestive heart failure

          -  anything that contraindicates a MRI investigation (e.g. pacemaker, claustrophobia,
             intracranial clips)

          -  lack of suitability for participation in the trial, for any reason, as judged by the
             Investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertil Lindahl, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bertil Lindahl, professor</last_name>
    <phone>+46 18 611 95 05</phone>
    <email>bertil.lindahl@ucr.uu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Falu Hospital</name>
      <address>
        <city>Falun</city>
        <zip>SE - 791 82</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pär-Lennart Ågren</last_name>
      <phone>+46 23 492 000</phone>
      <email>par-lennart.agren@ltdalarna.se</email>
    </contact>
    <investigator>
      <last_name>Pär-Lennart Ågren</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gävle Hospital</name>
      <address>
        <city>Gävle</city>
        <zip>SE - 801 82</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Svennberg</last_name>
      <phone>+46 26 154 000</phone>
      <email>lars.svennberg@lg.se</email>
    </contact>
    <investigator>
      <last_name>Lars Svennberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>SE - 581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Wodlin</last_name>
      <phone>+46 10 183 00 00</phone>
      <email>peter.wodlin@lio.se</email>
    </contact>
    <investigator>
      <last_name>Peter Wodlin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Danderyds Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>SE - 182 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pia Lundman</last_name>
      <phone>+46 8 65 55 000</phone>
      <email>pia.lundman@ds.se</email>
    </contact>
    <investigator>
      <last_name>Pia Lundman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>SE-751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertil Lindahl</last_name>
      <phone>+46 18 611 95 05</phone>
      <email>bertil.lindahl@ucr.uu.se</email>
    </contact>
    <investigator>
      <last_name>Bertil Lindahl, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>SE-701 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stella Cizinsky</last_name>
      <phone>+46 19 602 10 00</phone>
      <email>stella.cizinsky@orebroll.se</email>
    </contact>
    <investigator>
      <last_name>Stella Cizinsky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2010</study_first_posted>
  <last_update_submitted>December 8, 2010</last_update_submitted>
  <last_update_submitted_qc>December 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>professor Bertil Lindahl</name_title>
    <organization>Uppsala Clinical Research Centre</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

